Linical Co., Ltd. (TYO:2183)
220.00
+1.00 (0.46%)
Jun 3, 2026, 3:30 PM JST
Linical Market Cap
Linical has a market cap or net worth of 4.97 billion as of June 3, 2026. Its market cap has decreased by -26.17% in one year.
Market Cap
4.97B
Enterprise Value
2.01B
Revenue
8.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
220.00
Market Cap Chart
Since October 27, 2008, Linical's market cap has decreased from 9.24B to 4.97B, a decrease of -46.22%. That is a compound annual growth rate of -3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.95B | -25.26% |
| Dec 30, 2025 | 6.62B | -15.80% |
| Dec 30, 2024 | 7.86B | -34.34% |
| Dec 29, 2023 | 11.97B | -23.19% |
| Dec 30, 2022 | 15.58B | -11.31% |
| Dec 30, 2021 | 17.57B | 10.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 6.81B |
| StemCell Institute | 6.69B |
| Soiken Holdings | 6.43B |
| Chiome Bioscience | 5.96B |
| TMS Co., Ltd. | 5.91B |
| Noile-Immune Biotech | 5.85B |
| PRISM BioLab Co.,LTD | 5.29B |
| Kohjin Bio | 5.15B |